Inhibitors of phospholipase enzymes
US6630496B1 · kind B1 · utility
96Cited by
41References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2000 |
| Grant date | Oct 7, 2003 |
| Priority date | — |
| Expiry date | Aug 24, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides substituted indole and indoline compounds useful in inhibiting phospholipase activity, particularly including cytosolic phospholipase A2 (cPLA2) activity, as well as pharmaceutical compositions containing the compounds and methods of using them to treat various maladies, including pain and inflammatory conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.